Medicines | Webnewswire

Home Tags Medicines

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights...

Editor - October 31, 2025 0

Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase...

Leslie Atkins - October 14, 2025 0

Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies...

Editor - September 4, 2025 0

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking...

Leslie Atkins - August 14, 2025 0

Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan

Correspondent - August 8, 2025 0

Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global...

Editor - August 4, 2025 0

Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in...

Editor - July 5, 2025 0

Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater...

Editor - December 19, 2024 0

Everest Medicines Announces NEFECON(R)’s Full Approval in South Korea

Correspondent - November 20, 2024 0

Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment...

Editor - October 21, 2024 0

Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives...

Editor - October 21, 2024 0

Kingworld Medicines Expects 1H Profit Increased By 35%-40%

August 3, 2023 0

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Zolbetuximab

July 17, 2023 0

Get $10 by answering a Simple Survey. Click Here